TY - JOUR
T1 - SIOP PODC adapted risk stratification and treatment guidelines
T2 - Recommendations for acute myeloid leukemia in resource-limited settings
AU - Bansal, Deepak
AU - Davidson, Alan
AU - Supriyadi, Eddy
AU - Njuguna, Festus
AU - Ribeiro, Raul C.
AU - Kaspers, Gertjan J.L.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - In low- and middle-income countries (LMICs), limited resources, suboptimal risk stratification, and disproportionate patient-to-infrastructure ratio result in low survival of patients with acute myeloid leukemia (AML). A high incidence of relapse, inherent to the biology, renders management arduous. The challenge of treating AML in LMICs is of balancing the intensity of myelosuppressive chemotherapy, which appears necessary for cure, with available supportive care, which influences treatment-related mortality. The recommendations outlined in this paper are based on published evidence and expert opinion. The principle of this adapted protocol is to tailor treatment to available resources, reduce preventable toxic death, and direct limited resources toward those children who are most likely to be cured.
AB - In low- and middle-income countries (LMICs), limited resources, suboptimal risk stratification, and disproportionate patient-to-infrastructure ratio result in low survival of patients with acute myeloid leukemia (AML). A high incidence of relapse, inherent to the biology, renders management arduous. The challenge of treating AML in LMICs is of balancing the intensity of myelosuppressive chemotherapy, which appears necessary for cure, with available supportive care, which influences treatment-related mortality. The recommendations outlined in this paper are based on published evidence and expert opinion. The principle of this adapted protocol is to tailor treatment to available resources, reduce preventable toxic death, and direct limited resources toward those children who are most likely to be cured.
KW - acute myelogenous leukemia
KW - acute nonlymphoblastic leukemia
KW - chemotherapy
KW - developing country
KW - low and middle income
KW - protocol
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85075732776&partnerID=8YFLogxK
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075732776&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31774234
U2 - https://doi.org/10.1002/pbc.28087
DO - https://doi.org/10.1002/pbc.28087
M3 - Article
C2 - 31774234
SN - 1545-5009
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
M1 - e28087
ER -